Search

Electrical cables provide essential functions, such as delivery of power or instrumentation signals for monitoring systems. Most cables installed in industrial applications are constructed with organic polymer insulations that can become brittle, crack, or degrade over time from exposure to harsh environmental conditions, such as elevated temperatures, moisture, vibration, mechanical shock, and radiation. This paper describes an overall strategy for assessing the health and managing the aging of cables during the operating life of an industrial facility. This strategy involves performing condition assessments and monitoring of electrical cables using both in situ and laboratory testing techniques. It includes in situ testing to identify anomalies in the circuits, such as degraded terminations, splices, connections, and degraded sections of cable insulation, as well as as-found evaluations to determine the current condition of installed cables. These cable condition evaluations provide important information about the current state of the cable circuits. Moreover, the test results can be used to trend/monitor age-related degradation and estimate the remaining useful life of installed cables. [ABSTRACT FROM AUTHOR]

Abstract: We apply the MC@NLO formalism to the production of heavy-quark pairs in pointlike photon–hadron collisions. By combining this result with its analogue relevant to hadron–hadron collisions, we obtain NLO predictions matched to parton showers for the photoproduction of pairs. We compare MC@NLO results to the measurements of c- and b-flavoured hadron observables performed by the H1 and ZEUS Collaborations at HERA. [Copyright &y& Elsevier]

Flow cytometry methods currently used for measuring neutrophil activation involve sample manipulation, which may result in cellular depletion and artifactual activation. To design a new methodology for measurement of neutrophil activation with minimal sample manipulation. Oxidative burst and CD 11b neutrophil expression were simultaneously assessed by a new no-lyse no-wash technique and a standard lyse-method in 10 pediatric patients with recurrent infections and two patients with chronic granulomatous disease (CGD). The new technique was based on nucleic acid staining to discriminate erythrocytes and debris without requiring physical separation. Both methods served equally to confirm or eliminate the diagnosis of CGD and leukocyte adhesion deficiency type 1. The values of baseline CD11b and oxidative burst obtained using the lysis method were significantly higher than those obtained by the no-lyse no-wash method. After activation, the lysis method resulted in higher neutrophil depletion (41%vs.19%,P = 0.03). When compared with standard methods, neutrophil activation assessment by a no-lyse no-wash method resulted in lower neutrophil depletion and differences in oxidative burst and CD11b neutrophil values. [ABSTRACT FROM AUTHOR]

Immune tolerance induction ( ITI) can overcome inhibitory factor VIII (FVIII) antibodies in haemophilia A patients receiving FVIII replacement therapy. The objective was to evaluate the use of sucrose-formulated, full-length recombinant FVIII ( rFVIII-FS) for ITI therapy. Patients (<8 years at ITI start) with severe haemophilia A and a peak inhibitor titre >5 Bethesda units (BU) who underwent ITI with any rFVIII-FS dose for ≥9 months (or until success) were eligible for this retrospective study. Efficacy analyses included descriptions of ITI treatment regimens and outcomes; ITI success was determined solely at the discretion of the investigator. Safety analyses included assessment of adverse events. Of 51 enrolled patients, 32 [high dose (≥85 IU kg−1 day−1), n = 21; low dose, n = 11] were eligible for analysis. ITI was successful in 69% (22/32) of patients (high dose, 66.7%; low dose, 72.7%) after a median of 1.4 years (range, 0.1-3.6 years). Influencing factors for ITI success were start of ITI <1 year after inhibitor detection and an inhibitor titre <10 BU at ITI start. All patients successfully tolerized with ITI continued to receive rFVIII-FS prophylaxis as maintenance therapy, with no inhibitor recurrence from the end of ITI until study enrolment. Use of rFVIII-FS for ITI was effective and well tolerated; success rates were similar to those in published studies. [ABSTRACT FROM AUTHOR]

Bone Marrow Transplantation (2003) 31, 517-518. doi:10.1038/sj.bmt.1703907 [ABSTRACT FROM AUTHOR]

Presents a study that evaluated the safety and efficacy of high-dose granulocyte colony-stimulating factor alone for PBSC mobilization in children. Methodology; Findings; Conclusion.

Reports on the results of in vitro cultures of circulating myeloid progenitor cells. Reactive thrombocytosis; Megakaryocytic progenitors; Lack of endogenous growth.